Zhejiang Hisun Pharmaceutical (600267.SH) releases a forecasted profit, estimating a net profit of 570-630 million yuan in 2024, turning losses into profits.

22/01/2025

Guangzhou Pharmaceuticals Corporation (stock code: 600267.SH) announced that the company is expected to achieve attributable net profit to shareholders of the listed company for the year 2024...

Zhejiang Hisun Pharmaceutical (600267.SH) announced that the company expects to achieve a net profit attributable to shareholders of the listed company of 570 million to 630 million yuan in 2024, compared to a loss in the same period last year.

New stock news | Zijin Gold International submitted an application to the Hong Kong Stock Exchange. As of December 31, 2024, its gold reserves ranked ninth in the world.

New Stock News | Shandong Linglong Tyre (601966.SH) submits application to Hong Kong Stock Exchange, becoming China's largest OE tire manufacturer.

A-share subscription | Tongyu New Material (301630.SZ) opens for subscription, its wholly-owned subsidiary faces the risk of loss

New stock news | Zijin Gold International submitted an application to the Hong Kong Stock Exchange. As of December 31, 2024, its gold reserves ranked ninth in the world.

New Stock News | Shandong Linglong Tyre (601966.SH) submits application to Hong Kong Stock Exchange, becoming China's largest OE tire manufacturer.

A-share subscription | Tongyu New Material (301630.SZ) opens for subscription, its wholly-owned subsidiary faces the risk of loss